USA Facial Injectables Market Size Likely to Surpass at a CAGR of 15.2% By 2033

As per the current market research conducted by CMI Team, the USA Facial Injectables Market size is expected to record a CAGR of 15.2% from 2024 to 2033. In 2024, the market size is projected to reach a valuation of 3,446.83 Million and in 2023 the market is projected at USD 3,121.04 Million. By 2033, the valuation is anticipated to reach USD 4,619.6 Million.

USA Facial Injectables Market: Growth Factors and Dynamics

• Rising Demand for Non-Invasive Cosmetic Procedures: Facial injectables are gaining favor with consumers because the recovery periods for procedures are much shorter, the risks involved, and the cost associated with them are much lower and much more affordable than invasive surgical procedures. Easy and cheap procedures drive the market higher because people desire to look better but do not want to be operated on.

• Aging Population: The population is gradually growing older in the USA and the people who need facial injectables are doing this to try to arrest anti-aging signs like lines and loss of facial volume. This is a major market opportunity as organizations are presented with an opportunity to make goods and services required by the aging personnel available.

• Technological Advancements: The expanded procedures related to the injections of some products and methods have increased the safety and effectiveness of the outcomes and their duration. Opportunities for the fillers market are represented by the availability of more effective products, longer filler lifespan, and improved botulinum toxin preparations.

• Influence of Social Media and Celebrity Endorsements: Social media and celebrities have made beauty as easily accessible and familiar, hence creating procedures such as facial injectables culture. This visibility has aided this market penetration, especially with the youthful people, and provides direction in the case of market segment and customer allegiance.

• Increasing Awareness and Acceptance: Customers erase social stigmas connected with such treatment due to the availability of information concerning different kinds of facial injectables. It controls the market force and new product chances through knowledge from awareness campaigns and access to information, putting confidence in themselves to make the right choice.

USA Facial Injectables Market: Key Developments

• In August 2024, L’Oréal acquired a 10% stake in Galderma Group AG from Sunshine SwissCo AG. The financial terms were not disclosed. The two groups will also form a strategic scientific partnership, combining Galderma’s dermatological expertise with L’Oréal’s knowledge of skin biology and diagnostic tools.

• In January 2024, Novaestiq Corp. announced a definitive agreement with Croma-Pharma GmbH for the exclusive U.S. distributorship of the Saypha® line of dermal fillers.

• In May 2023, Evolus, Inc. said it had entered into a definitive agreement to be the exclusive U.S. distributor of a new line of five distinct dermal fillers in late-stage development.

Report Scope

USA Facial Injectables Market: COVID-19 Analysis

The COVID-19 pandemic significantly impacted the USA facial injectables market in various ways:

• Impact on Market Dynamics: The COVID-19 pandemic severely affected the USA facial injectables market as lockdowns, social distancing, and the shutdown of many businesses affected the market. Man, aesthetic clinic, and MedSpas had their operation interrupted for an extended period, hence causing a reduction in the number of elective surgeries. Thus, consumer confidence and their expenditure for cosmetic amplifications were reduced during the early stages of the emergence of a pandemic.

• Shift in Consumer Behavior: COVID-19 has forced the health sector and people to embrace remote services and virtual consultations with aesthetic practitioners. A lot of consumers started seeking aesthetic treatments from home so, various companies ventured into manufacturing and marketing home skincare and injectable solutions. Also, spending on personal care and health and personal care goods saw rebounding effects as people flexed towards self-care as restrictions were relaxed.

• Operational Adjustments: Specialists who deliver facial injectable services had to change their practice due to new extra precautions in light of the pandemic. This was done by acting early and effectively in hygiene, the minimization of face-to-face contacts, and the optimization of general patient identification. Some clinics boosted their cleanliness levels and made physical health payments to give patients reassurance and confidence.

• Market Recovery and Growth: When the vaccination rates went high and the restrictions relaxed, the market for facial injectables started recovering. Manufacturers and service providers in the industry leveraged the pent-up demand for cosmetic and aesthetic services as consumers returned to services they delayed. After the pandemic, there was a demand revival in the market, and consumers desired to improve their self-image and appearance.

• Long-Term Effects: COVID has made some changes in the market permanent, and among them is an increased focus on online communication and teleconsultation. Further development toward more flexibility and additional accessibility of treatment offers will likely proceed, and providers will establish telemedicine and virtual consultation offers in the service portfolio. It has also highlighted the significance of the health and safety of aesthetic practices and has become the guide to the business’s future operations.

Overall, while the pandemic posed challenges to the USA facial injectables market, it also accelerated certain trends and highlighted the resilience and adaptability of the industry in meeting evolving consumer needs during global disruptions.

List of the prominent players in the USA Facial Injectables Market:

• Allergan Aesthetics (A division of AbbVie Inc.)
• Galderma Laboratories L.P.
• Revance Therapeutics Inc.
• Merz Pharmaceuticals LLC
• Ipsen Biopharmaceuticals Inc.
• Suneva Medical Inc.
• Prollenium Medical Technologies Inc.
• Teoxane Laboratories
• Hugel Inc.
• Croma-Pharma GmbH
• Daewoong Pharmaceutical Co. Ltd.
• Bloomage BioTechnology Corporation Limited
• Syneron Candela
• Sinclair Pharma
• Revance Aesthetics (Part of Revance Therapeutics)
• Others

The USA Facial Injectables Market is segmented as follows:

By Product

• Collagen & PMMA Microspheres
• Hyaluronic Acid (HA)
• Botulinum Toxin Type A
• Calcium Hydroxylapatite (CaHA)
• Poly-L-lactic Acid (PLLA)
• Others

By Application

• Facial Line Correction
• Lip Augmentation
• Face Lift
• Acne Scar Treatment
• Lipoatrophy Treatment
• Others

By End-Use

• MedSpas
• Dermatology Clinics
• Hospitals